The novel assertion of the danger-difference-sensing hypothesis is that reference cells affect lymphocyte cytotoxicity in a reverse manner, i.e. that low-levels of danger-signals on non-cognate targets increase T cell (Tc) cytotoxicity, and conversely, that high-levels of danger signals on non-cognate targets decrease cytotoxicity.
Sensitivity of these tests for disproving theories
The three-party cytotoxicity tests described herein will
discover whether the level of danger-signals on non-cognate targets
affects cytotoxicity against cognate targets.
The known reverse-signalling effect of FasL suggests that adding Fashi
or MICAhi
bystanders would increase cytotoxicity. The conventional danger-model
would predict that adding NKG2D ligands to a cytotoxicity assay would always
increase cytotoxicity, due to the general, proinflammatory
effect of danger signals. In contrast, the reference-cell theory
predicts that such additional cells would decrease cytotoxicity.
As for adding low-danger, non-cognate targets, one would expect they would consume time and metabolic resources from the effectors and would therefore reduce net cytotoxicity. In contrast, the reference-cell theory predicts that low-danger non-cognate targets should increase cytotoxicity against cognate targets. Therefore both the low-danger-reference and high-danger-reference assays described below form very sensitive ways of distinguishing between successful and unsuccessful theories. Background
The experiments will resemble bystander toxicity assays where non-cognate targets are added to standard two-party (effector and target) toxicity assays. Heretofore the additional cells have been called "bystanders", and cytotoxicity against them has been what was measured. I propose measuring how the non-cognate targets affect cytotoxicity against cognate targets. If the presence of non-cognate targets bearing high levels of danger signals, reduces cytotoxicity against cognate targets, then we have confirmation that we can call the non-cognate targets "reference" cells instead of just "bystanders". In order to reduce the complexity of interpretation I would recommend that all three cell parties (cognate targets, effectors, and reference targets) be syngeneic with each other. As referenced at length in my paper on Ag correlation, many cytotoxicity assays have shown that syngeny is mandatory for FasL probing of (non-cognate) "bystanders" after T cells (Tc) engage cognate targets, so reference cells at least must be syngeneic with effectors.
CD8+ effectors are more likely than CD4+ Tc, to produce comprehensible results in these experiments. There are both specific and general reasons for the preference for killer rather than helper T cells. Suzuki and Fink's data show that CD8+ cells proliferate in response to ligating their FasL with cognate targets' Fas, whereas CD4+ cells do not. One simple explanation for that difference is that antibody-mediated responses are directed against necrotically lysing viruses, whereas cytotoxicity is directed against viruses that do not burst open their host cells in order to escape. A simple (perhaps old-fashioned and overly simplistic) model of T cell compartments would consider CD8+ Tc to be killers, and CD4+ Tc to be helpers of B cells.
CD4+ cells seem to have more known interactions with other immune cells, so their interactions with potential reference cells could be more difficult to interpret. When CD4+ cells are eventually tested for their response to reference cells, one should be careful to discriminate between CD25+ regulator cells and CD25- helper cells, since they would be likely to behave in opposition to each other. It would be interesting to test whether CD4+ cells react to opsonization as a danger signal. Of course it makes no sense to consider opsonization as a danger-signal from the point of view of the immune system as a whole, because the immune system produces the opsonization. However, individual cells need to process data semi-autonomously, so an immune system in which some of its components treat markers produced by other immune cells as danger-signals, could be efficient as a distributed processing system.
Target cells
The cognate (primary) and non-cognate (reference) targets should be as
similar as possible to each other, except for cognate-antigen and danger-signal
presentation.
Tissue similarity between primary targets and reference targets
is necessary because in-vivo Tc face many
extraneous local cell-types that should not be used to measure the reference
levels of danger signals of the local tissue of interest. For example, if Tc
must evaluate the danger-signals presented by muscle cells,
nearby nerve fibers and blood vessel cells would be likely to display
different levels of danger signals than healthy muscle cells. Therefore it
is quite likely that Tc have evolved to be unresponsive to background levels
of danger-signals as presented by nearby non-cognate cells of dramatically
different tissue types.
Ideally none of the assay cells would be transformed cell lines, but if culture of transfected, non-transformed cells is too difficult or slow, then parental and transfected immortalized cell lines could be used. A parental line could be transfected to express Fas receptor, and a ligand of NKG2D. H-Y would serve as the cognate antigen; Fas and/or a ligand of NKG2D would be danger signals. Eight cell lines could result, ranging from cells expressing no more than background levels of Fas and MICA, and no H-Y, to cells expressing large quantities of all three molecules. More cell lines could be created if transfected cells express varying amounts of the transfected genes. The estimate of eight cell lines assumes the transfection success would be binary for each of the three transfected genes; i.e. that transfected cells either express uniform amount of the targeted protein, or they express or increase their expression not at all. Intermediate expression of transfected genes would be very useful for advanced experiments, but the simple assays listed below require cells with just high or low (or zero in the case of H-Y) expression levels. (I deem it unlikely, but there is a possibility that Tc might regard tissue cells absolutely devoid of danger signals, as being unreliable due to possible compromise by a pathogen. In that case, cells displaying low, but not completely negligible levels of danger signals would be necessary for enhancing reference targets.)
Preparation of effector cells
Ensure T cells are primed, but not by dendritic cells that matured when
they were embedded in tissue that began secreting danger signals before necrosis.
Priming by dendritic cells that absorbed H-Y with necrotic debris would be acceptable.
It might be helpful to allow two months (rather than two weeks) of rest after priming, to allow Tc stimulated
by DC to recover from that acute stimulation; When
highly stimulated by dendritic cells, Tc need to temporarily ignore the lack of
danger-correlation to early viral proteins because some viruses
have evolved to temporally separate
danger-signals from their epitopes. By allowing the responder Tc to
shift into a memory-state instead of testing them during high-activation after priming,
they are more likely to respond to relatively lower levels of danger-signals on
cognate targets, by reducing cytotoxicity.
Appended 2007 June 25:
The vaccination methods are obviously
good things to vary to ascertain how autonomous differential danger sensing
by Tc, interacts with response to activation by APCs.
Assay guidelines
As per standard practice, cytotoxicity should be measured with varying
ratios of effectors to targets. My hope is that when low-danger reference
cells are added, high cytotoxicity can be achieved even when targets greatly
outnumber effectors. The fact that effectors usually need to outnumber
targets in order to kill a substantial fraction of them in four hours, seems
an indication that something has been missing from our
assays. My hope is that the missing ingredient is reference targets. It
is desirable to test high ratios of targets to effectors for another reason,
too; then effectors will be less likely to use other effectors as references.
Duke shows that effectors seem to prefer non-lymphocytes as reference targets
(bystanders affected by FasL on effectors that kill cognate targets). However,
restricting reference effects to cells that we specifically add as references,
will make our data easier to interpret. I recommend that the initial
tests use equal numbers of reference and cognate targets.
In addition to these described assays, it would be helpful to at least at first, simultaneously run assays of cytotoxicity against bystanders, just to verify that the experiment successfully duplicates conditions previously published in which syngeny was found necessary for bystander lysis. Descriptions of such assays can be found in:
Assay cell sets
The following discussion uses the notation (low) for cells that display
low levels of a given danger signal. Ideally such levels would be those
typical of normal, mature cells in a given tissue type. However it may
be difficult to culture healthy, mature cells, so blast cells might be a
reasonable alternative. If necessary, transformed cell lines might be
used, in which case (low) might mean absolutely zero expression of a given
danger signal. I do not know whether complete extinction of danger signals
will be interpreted by immune cells as a danger signal in itself.
All primary targets will express the cognate Ag, e.g. H-Y. No reference target will express the cognate Ag.
| Assay Name |
Cognate Targets |
Reference Targets |
| Control 1 |
MICAhi, Fashi |
(None) |
| Control 2 |
MICAhi, Fashi |
MICAhi, Fashi |
| Double danger difference |
MICAhi, Fashi |
MICAlow, Faslow |
| Fas-only danger difference |
MICAlow, Fashi |
MICAlow, Faslow |
| MICA-only danger difference |
MICAhi, Faslow |
MICAlow, Faslow |
| Assay Name |
Cognate Targets |
Reference Targets |
| Control 1 |
MICAlow, Faslow |
(None) |
| Control 2 |
MICAlow, Faslow |
MICAlow, Faslow |
| Double danger difference |
MICAlow, Faslow |
MICAhi, Fashi |
| Fas-only danger difference |
MICAhi, Faslow |
MICAhi, Fashi |
| MICA-only danger difference |
MICAlow, Fashi |
MICAhi, Fashi |
Confounding effects of competition
A positive result from the cytotoxicity inhibition assays, could be interpreted as
due to competition for the attentions of effectors by high-danger bystander targets,
rather than as due to effectors comparing the danger signals on cells serving as
references.
Modified 2007 June 25: Ascribing inhibition to competition (instead of reference-cell effects) raises a philosophical ambiguity; competition could said to be a mechanism of reference-cell effects! However, it would be disirable to distinguish between reference-cell effects and target competition; that would provide a cleaner explanation and test of the hypothesis. Although a 50% decrease in cytotoxicity could reasonably be blamed on competition from a number of reference cells equal to the number of primary targets, a decrease of 90% or more, would be more plausibly the result of reference-comparision effects. But how to prove that? One could condition the effectors with both cognate targets and non-cognate reference cells for hours or days, then separate effectors out and drop them into assay wells with only labelled cognate targets. The addition of reference cells to a conditioning regimen would not influence later cytotoxicity via competition effects, as long as the reference cells had been effectively excluded from the ensuing assay.
The use of a lengthy conditioning step prior to the assay, also allows one to measure long-response times to reference cells. 51Cr cytotoxicity assays can be difficult to extend past 12 hours due to high levels of background cell-death and 51Cr escape. I expect it to take many days or weeks to overcome the stimulation of a DC embedded in tissue, that had detected first an early viral protein, then danger signals. While such a long assay might be infeasible, we have no way apriori to know how long it might take the effects of refernce cells to overcome other starting conditions and states of T cells, such as would be the case for either unprimed thymic emigrants on the one hand, or for Tc recently activated by DC that had collected cognate peptides together with floating danger signals (LPS, hyppos, etc.) Perhaps running a conditioning step for several days, as Coudert and coworkers did on NK cells, might be both feasible and useful.
An alternative way of distinguishing between reference-cell and competitive effects, would be to vary the number of high-danger reference targets while keeping the total fluid volume and other variables constant. Doubling or halving the concentration of reference targets should have a dramatic effect on cytotoxicity if the competition is limiting cytotoxicity, but would not necessarily greatly affect cytotoxicity due to reference-sensing effects that do not rely on competition for an inhibition mechanism.
Note that a positive result from cytoxicity enhancement assays which add low-danger reference cells, could only be explained by reference-target effects. Competition would always decrease cytotoxicity, not boost it.